[1]
2019. Can Rare Cancer Drugs Expect Sales in Japan?: A Prescription Pattern Analysis of Drugs for Chronic Myelogenous Leukemia and Neuroendocrine Tumor. Journal of Regulatory Science. 7, (Feb. 2019), 1–9. DOI:https://doi.org/10.21423/JRS-V07SHIBATA.